SCM LIFESCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,905 KRW | -0.68% |
|
-3.17% | -23.15% |
| 2023 | SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index | CI |
| 2023 | SCM LifeScience to Raise 30.9 Billion Won via Share Issuance | MT |
| Sales 2022 | 396M 290K | Sales 2023 | 696M 509K | Capitalization | 77.37B 56.63M |
|---|---|---|---|---|---|
| Net income 2022 | -22.93B -16.78M | Net income 2023 | -23.96B -17.54M | EV / Sales 2022 | 434 x |
| Net cash position 2022 | 3.2B 2.34M | Net cash position 2023 | 8.52B 6.23M | EV / Sales 2023 | 99 x |
| P/E ratio 2022 |
-6.35
x | P/E ratio 2023 |
-2.58
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.26% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.68% | ||
| 1 week | -3.17% | ||
| Current month | +5.64% | ||
| 1 month | +0.35% | ||
| 3 months | +2.83% | ||
| 6 months | +3.20% | ||
| Current year | -23.15% |
1 week
2 850.00
3 010.00
1 month
2 700.003 260.00
Current year
2 520.004 300.00
1 year
2 060.0011 150.00
3 years
2 060.0029 375.00
5 years
2 060.0050 250.00
10 years
2 060.0050 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Suk-Woo Oh
COO | Chief Operating Officer | - | - |
Sun-Wook Song
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 2,905 | -0.68% | 24,639 |
| 24-05-27 | 2,925 | +0.34% | 46,770 |
| 24-05-24 | 2,915 | -1.52% | 25,240 |
| 24-05-23 | 2,960 | -1.33% | 33,668 |
| 24-05-22 | 3,000 | 0.00% | 45,953 |
End-of-day quote Korea S.E., May 27, 2024
More quotes
SCM Lifescience Co Ltd is a Korea-based company engaged in the research and development of medicines. The Company is engaged in the business of the development and production of cell therapy products, the agency testing of cell production and quality, adult stem cell consulting, cosmetics manufacturing, and hair growth protein manufacturing.
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -23.15% | 43.76M | |
| +9.83% | 115B | |
| +10.80% | 105B | |
| -10.84% | 22.71B | |
| -1.08% | 21.83B | |
| -10.51% | 18.18B | |
| -41.92% | 16.52B | |
| -15.11% | 16.01B | |
| +6.62% | 14.14B | |
| +17.53% | 10.71B |
- Stock Market
- Equities
- A298060 Stock
